TY - JOUR AU - Shambo Samrat Samajdar AU - Shrestha Dutta AU - Aneek Ghosh AU - Shatavisa Mukherjee AU - Jayanta Sharma AU - Anwesha Behera AU - Oyendrilla Mitra AU - Ishanee Das Sharma AU - Mohojit Chakraborty AU - Santanu K Tripathi PY - 2022/06/01 Y2 - 2024/03/29 TI - Exploring position of colchicine in management of COVID 19 – A systematic review JF - Journal of Pharmacovigilance and Drug Research JA - jpadr VL - 3 IS - 2 SE - Reviews DO - 10.53411/jpadr.2022.3.2.4 UR - https://jpadr.com/index.php/jpadr/article/view/73 AB - Introduction: One of the goals of managing COVID 19 patients is controlling inflammatory responses, which are majorly responsible for morbidity and mortality associated with SARS CoV 2 infection. A novel approach to address inflammation could be Colchicine. It invariably decreases pulmonary complexities, showing antimitotic action, causing metaphase arrest by inhibiting microtubule and spindle formation, and is effective in reducing granulocyte migration, ultimately reducing inflammation.Method: For this systemic review, literature was searched using PubMed, Embase, Cochrane Central, medRxiv, and researchsquare.com. The keywords used were – COVID 19, colchicine, SARS-CoV-2, and clinical outcome. Studies published between January 2020 and October 2021 were evaluated and screened to identify those that had reported the effect of colchicine in SARS CoV 2 infected patients and to assess clinical outcomes including mortality, intensive care unit (ICU) admissions, or mechanical ventilation.Results and Discussion: In this systematic review among 8 quantitative clinical researchers, it was observed that colchicine administration was related to improved clinical outcomes in COVID 19 patients, without statistical significance.Conclusion: The mortality risk of COVID-19 patients can be reduced by colchicine. Need more prospective clinical researches which could help to evaluate the efficacy of colchicine to treat COVID-19 patients in different stages of the disease, including post-hospitalization and long-term care follow-up. ER -